250 related articles for article (PubMed ID: 26946067)
21. Best evidence topic reports. BET 3: Topical intranasal tranexamic acid for spontaneous epistaxis.
Hilton L; Reuben A
Emerg Med J; 2014 May; 31(5):436-7. PubMed ID: 24846097
[TBL] [Abstract][Full Text] [Related]
22. Topical application of tranexamic acid in anticoagulated patients undergoing minor oral surgery: A systematic review and meta-analysis of randomized clinical trials.
de Vasconcellos SJ; de Santana Santos T; Reinheimer DM; Faria-E-Silva AL; de Melo MF; Martins-Filho PR
J Craniomaxillofac Surg; 2017 Jan; 45(1):20-26. PubMed ID: 27840121
[TBL] [Abstract][Full Text] [Related]
23. Role of topical tranexamic acid in the management of idiopathic anterior epistaxis in adult patients in the emergency department.
Logan JK; Pantle H
Am J Health Syst Pharm; 2016 Nov; 73(21):1755-1759. PubMed ID: 27769971
[TBL] [Abstract][Full Text] [Related]
24. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease.
Gaillard S; Dupuis-Girod S; Boutitie F; Rivière S; Morinière S; Hatron PY; Manfredi G; Kaminsky P; Capitaine AL; Roy P; Gueyffier F; Plauchu H;
J Thromb Haemost; 2014 Sep; 12(9):1494-502. PubMed ID: 25040799
[TBL] [Abstract][Full Text] [Related]
25. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
[TBL] [Abstract][Full Text] [Related]
26. Evaluating three hundred and fifty-two admissions and predictors of re-admissions for epistaxis - is it time to re-evaluate tranexamic acid in epistaxis?
Jervis S; Saunders T; Belcher J; Skinner D
Clin Otolaryngol; 2017 Apr; 42(2):439-442. PubMed ID: 26681525
[No Abstract] [Full Text] [Related]
27. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
Sabbà C; Gallitelli M; Palasciano G
N Engl J Med; 2001 Sep; 345(12):926. PubMed ID: 11565536
[No Abstract] [Full Text] [Related]
28. Treatment of bleeding upper aerodigestive tract tumor-a novel approach with antifibrinolytic agent: case series and literature review.
Low TH; Huang J; Reid C; Elliott M; Clark JR
Laryngoscope; 2013 Oct; 123(10):2449-52. PubMed ID: 23553514
[TBL] [Abstract][Full Text] [Related]
29. Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta-analysis.
Hsu YP; Hsu CW; Bai CH; Cheng SW; Chen C
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):22-35. PubMed ID: 30200816
[TBL] [Abstract][Full Text] [Related]
30. Topical tranexamic acid (TXA) for the management of a bleeding arteriovenous fistula.
Eberle ML; Schechter-Perkins EM; Altawil Z
Am J Emerg Med; 2020 Feb; 38(2):407.e5-407.e6. PubMed ID: 31685307
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of tranexamic acid using oral administration in total knee arthroplasty: a systematic review and meta-analysis.
Zhang LK; Ma JX; Kuang MJ; Zhao J; Lu B; Wang Y; Ma XL; Fan ZR
J Orthop Surg Res; 2017 Oct; 12(1):159. PubMed ID: 29078788
[TBL] [Abstract][Full Text] [Related]
32. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia.
Klepfish A; Berrebi A; Schattner A
Arch Intern Med; 2001 Mar; 161(5):767. PubMed ID: 11231712
[No Abstract] [Full Text] [Related]
33. Topical Tranexamic Acid Compared With Anterior Nasal Packing for Treatment of Epistaxis in Patients Taking Antiplatelet Drugs: Randomized Controlled Trial.
Zahed R; Mousavi Jazayeri MH; Naderi A; Naderpour Z; Saeedi M
Acad Emerg Med; 2018 Mar; 25(3):261-266. PubMed ID: 29125679
[TBL] [Abstract][Full Text] [Related]
34. Is Tranexamic Acid (TXA) Effective Compared with Anterior Nasal Packing (ANP) in Achieving Cessation of Bleeding in Patients with Anterior Epistaxis?
Torres E; Johnson MY; Seebald K; Kachhi P
J Emerg Med; 2022 Jun; 62(6):820-825. PubMed ID: 35545485
[No Abstract] [Full Text] [Related]
35. Comparison of the effectiveness and safety of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials.
Chen TP; Chen YM; Jiao JB; Wang YF; Qian LG; Guo Z; Ma Z; Han CY; Shi TH
J Orthop Surg Res; 2017 Jan; 12(1):11. PubMed ID: 28103911
[TBL] [Abstract][Full Text] [Related]
36. Tranexamic acid in hereditary hemorrhagic telangiectasia.
Lozano M
N Engl J Med; 2002 Feb; 346(6):457. PubMed ID: 11832543
[No Abstract] [Full Text] [Related]
37. Comparative Effectiveness of Topically Administered Tranexamic Acid Versus Topical Oxymetazoline Spray for Achieving Hemostasis in Epistaxis.
Whitworth K; Johnson J; Wisniewski S; Schrader M
J Emerg Med; 2020 Feb; 58(2):211-216. PubMed ID: 31899024
[TBL] [Abstract][Full Text] [Related]
38. Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomised controlled trials.
Li JF; Li H; Zhao H; Wang J; Liu S; Song Y; Wu HF
J Orthop Surg Res; 2017 Feb; 12(1):22. PubMed ID: 28153031
[TBL] [Abstract][Full Text] [Related]
39. Evaluating Effectiveness of Nasal Compression With Tranexamic Acid Compared With Simple Nasal Compression and Merocel Packing: A Randomized Controlled Trial.
Akkan S; Çorbacıoğlu ŞK; Aytar H; Emektar E; Dağar S; Çevik Y
Ann Emerg Med; 2019 Jul; 74(1):72-78. PubMed ID: 31080025
[TBL] [Abstract][Full Text] [Related]
40. Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: An updated meta-analysis.
Xie J; Hu Q; Huang Q; Ma J; Lei Y; Pei F
Thromb Res; 2017 May; 153():28-36. PubMed ID: 28319822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
